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Christiana Care Health System
16th busiest hospital system in the nation 
$2.03 billion in total patient revenue 
> 17,000 employees and dependents
– largest private employer in Delaware 
Self-insured
Source: American Hospital Association Annual Survey Database of 
6,200 U.S. Hospitals, FY 2009, © Health Forum, LLC.
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How to Contain Cost Growth?
Cost-sharing (i.e. copayments, deductibles) 
– reduces unnecessary utilization
– reduces medication adherence
initiation and persistence
Solomon Archives Int Med 2009, Chernew et al.  Health Affairs 2007
Medication Adherence
Adherence ~ Outcomes
Low in diabetes and chronic conditions
– Oral hypoglycemics: 
~60% of patients with MPR > 80%
~60% with persistence at 12 months
Cramer  Int J Clin Pract 2007 
Sokol MC, Medical Care June 2005
Value-based Insurance Design
Patient costs reflect the true value of medical 
care/services
Eliminate cost barriers for high value services 
including essential medications
Copayment Elimination Program
18-month pilot program March 2009 – September 2010
Employees and dependents with diabetes are eligible
Eliminates copayments for ALL glycemic-related medications and supplies
Copayment Elimination Program
Previous copayment structure:
– 30 day:  $10/$25/$50
– 90 day:   $25/$63/$125 
Tier 2 and 3 medications required prior 
authorization according to PBM step-therapy 
guidelines
Program Requirements
On-line registration
Informed Consent (per IRB)
Baseline survey 
– demographic data
– diabetes complications and related comorbidities 
– self-reported medication adherence over previous week 
– cost-related nonadherence over previous year
Baseline measurements
– height, weight, A1c, LDL, and blood pressure
Follow-up survey, measurements, and labs at 12m
Participant Identification
Baseline Survey Results
and
Participant Characteristics
Age <18 9 (4%)
18-30 11 (5%)
30-40 21 (10%)
40-50 49 (23%)
50-60 98 (46%)
>60 23 (11%)
married 135 (64%)
race white 122(62%)
black 62 (30%)
other 21(10%)
income <50K 93 (48%)
50-100K 80 (41%)
>100K 22 (11%)
type 1 DM 45 (21%)
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Quality Measures
Baseline Clinical Measures
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Cost-related Nonadherence
Within the previous year have you 
decided not to refill medication, skipped 
medication doses, or taken a smaller 
medication dose because of expense
Report spending less money on food, 
heat, or other basic needs to afford 
diabetes medications
Pierre-Jacques et al.  Med Care 2008
Cost-Related Non-Adherence
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more likely if:
female
age less than 50
black
income <50K
higher comorbidity
Impact Evaluation
12 month 
Follow-Up
Goal 1: Reduce Cost Burden
P < 0.001
Monthly Out-of-pocket Expenses for 
Medications and Supplies 
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Cost-related nonadherence
P<0.001 for all 
comparisons
Cost-Related Nonadherence 
(Pre-Post)
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Goal 2: Increase Adherence
Helped Me Take My Diabetes Medications More 
Regularly
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Helped Me Check Blood Sugar More Regularly
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Self-Reported Adherence
Slight improvement in adherence to oral 
DM meds 
– Report missing at least 1 day in last week
32%  22%,   P = 0.028
No change in reported insulin adherence
Goal 3: Take Additional Medications
Helped Me Take Additional Diabetes Medications
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Helped Me Take Medications for Other Conditions
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Medication Use
11 not on any medications at start 
– 10 started medications
– 2 others stopped all medications
123 on oral medications at start
– 4 stopped
– 10 started
79 on insulin at start
– 11 stopped
– 9 started
Goal 4: Improve Glycemic Control
No differences by baseline CRN
pre post
A1c 7.8 +1.6 7.9 +1.7 NS
SBP 127.4 + 16.9 128.7+ 17.4 NS
LDL 100 + 33.3 108 + 37.8 p = 0.006
Overarching Goal: Help Employees
Helped Me Take Better Care of My 
Diabetes
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Donna Diorio, a hostess on 6-E at Christiana Hospital, is 
a participant in the original program ... The single mother 
of three says the program eliminates the burden and 
worry associated with paying for medications, needles 
and other medical equipment and also helps her to 
better control her diabetes.  “It is a Godsend,” she 
says. “The program allows me to focus on staying 
healthy rather than thinking about the cost of my 
drugs.”
Key Lessons and Implications
The Bottom Line…
Despite increases in reported adherence and 
decreases in reported cost-burden, Copayment 
Elimination Program appears to have minimal 
clinical benefit 
– Limitations
Uncontrolled pre-post
Small sample
Selection bias -- Ceiling Effect
May be consistent with VBID research
I chose not to participate in the Program because: n=108 %
I do not have diabetes 40 37
I was not aware of the Program 10 9
I have diabetes but do not take medications or use supplies 8 7
I do not have a problem affording diabetes medications or supplies 7 6
I have secondary insurance that covers my diabetes 
medications/supplies 6 6
I did not want CCHS to know my health information 5 5
It was too difficult to enroll in the program 8 7
I did not want to participate in a research program 22 20
Program Design May 
Influence Participation
Cost-Related Nonadherence 
is common and modifiable
~30% of our sample
More likely if black, has more comorbidities, and 
lower income
Copay Program decreased CRN
Heisler et al.  
Medical Care 2010
Glycemic control is difficult to “ENFORCE”
Lifestyle choices dominate
Adherence, even in setting of CRN, is not 
just about cost 
– Price elasticity may be largely unidirectional
– “once we have dealt with cost-related 
underuse, we must still address the numerous 
other reasons for nonadherence”
-Niteesh Choudry, Circulation 2009

Next Steps?
Controlled Analysis of Adherence and Costs
Employee disease management/wellness 
programs
– Linkage to HRA
Impact rather than observe real-life care…
– Linkage with PCP
Thank You
delliott@christianacare.org
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Adherence at CCHS
Limited information!
– 685 members with oral diabetes medication
– 569 with >2 glycemic meds
– MPR 81.4% (benchmark 87.7%)
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Non-participants
Is there a certain monetary value or other 
incentive that would have motivated you to 
participate? 
YES:     16 (15%)
NO:   55 (51%)
N/A 37 (34%)
If yes, what incentive would have motivated you 
to participate?
GiftCard 6 (38%)
Cash 5 (31%)
Premium reduction 11 (69%)
Free diab educ 4 (25%)

Operational Challenges
HIPAA, contracts, agreements, and 
corporate integrity
Partnership with Benefits Managers, 
Account administrator
Other considerations
Which problem/services to target? 
How comprehensively?
Which employees to target?
Other PR benefit
